bioRxiv ScienceSearch

bioRxiv · 10.1101/2020.01.16.908830

Serological evidence of exposure to Rift Valley, Dengue and Chikungunya Viruses among agropastoral communities in Manyara and Morogoro regions in Tanzania: A community Survey

Abstract

IntroductionTanzania has recently experienced outbreaks of dengue in two coastal regions of Dar es Salaam and Tanga. Chikungunya and Rift Valley Fever outbreaks have also been recorded in the past decade. Little is known on the burden of the arboviral disease causing viruses (Dengue, Rift Valley and Chikungunya) endemically in the inter-epidemic periods. We aimed at determining the prevalence of the dengue, rift valley and chikungunya among humans in two geo ecologically distinct sites. MethodologyThe community-based cross-sectional study was conducted in Magugu in Manyara region and Mvomero in Morogoro region in Tanzania. Venous blood was collected from participants of all age groups, serum prepared from samples and subjected to ELISA tests for RVFV IgG/IgM, DENV IgG/IgM, and CHIKV IgM/IgG. Samples that were positive for IgM ELISA tests were subjected to a quantitative RT PCR for each virus. A structured questionnaire was used to collect socio-demographic information. Data analysis was conducted using SPSSv22. ResultsA total of 191 individuals from both sites participated in the study. Only one CHIKV was detected in Magugu site but none of the 69 participants from Magugu site was seropositive or positive for RVFV and DENV. Of the 122 individuals from Wami-Dakawa site, 16.39% (n=20) had recent exposure to RVFV while 9.83% (n=12) were recently infected by Chikungunya virus. All samples were negative by RVFV and CHIKV qPCR. Neither Infection nor exposure to DENV was observed in participants from Wami-Dakawa. Risk factors associated with RVFV and DCHIKV seropositivity were being more than 5 in a household, having no formal education and having recently travelled to an urban area. ConclusionWe report an active circulation of RVFV and CHIKV in humans in Wami-Dakawa, in Mvomero district of Morogoro region during dry season, a higher rate of exposure to RVFV compared to CHIKV and an absence of circulating RVFV, DENV and CHIKV in humans in Magugu site in Manyara region. Author SummaryDengue, Chikungunya, rift valley and other viruses constitute an important group of etiologies of fever in Tanzania. In the past decade, Tanzania has experienced DENV and RVFV at different times. While RVFV outbreaks have occurred cyclically in approximately ten-year periods in Tanzania, DENV outbreaks have been more frequent since 2010. CHIKV infection is an important but largely unrecognized illness in Tanzania. In this study, we aimed to generate baseline data on the exposure and infection status of DENV, RVFV and CHIKV by detecting antibodies to the viruses and detecting the viruses in human subjects in two geo-ecological distinct sites. Neither infection nor exposure to the viruses were in observed in Magugu site in Manyara region, northern Tanzania. There was a significant exposure to RVFV (16.39%) and CHIKV (9.83%) in Wami-Dakawa but not to DENV in either site. None of the viruses was detected by PCR in any of the sites. Potential risks for exposure to CHIKV and RVFV were Larger numbers of household members, having no formal education and having recently travelled to an urban destination. Since arbovirus outbreaks are usually unpredictable, it is crucial to undertake active surveillance for RVFV, DENV, CHIKV and other viral agents in Tanzania.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Budodo, R. M., Horumpende, P. G., Mkumbaye, S. I., Mmbaga, B. T., Mwakapuja, R. S., Chilongola, J.. 2020-01-16. Serological evidence of exposure to Rift Valley, Dengue and Chikungunya Viruses among agropastoral communities in Manyara and Morogoro regions in Tanzania: A community Survey. https://doi.org/10.1101/2020.01.16.908830

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

A conserved cysteine-histidine-glutamate metal site identifies DUF501 (Rv1025), an essential uncharacterised protein family of Mycobacterium tuberculosis, as a candidate metalloenzyme and drug target

A substantial fraction of the Mycobacterium tuberculosis proteome remains functionally uncharacterised. Rv1025, a 155-residue protein carrying the domain of unknown function DUF501 (Pfam PF04417), is essential by transposon mutagenesis and vulnerable by CRISPR interference, an attractive but neglected drug target, yet has never been functionally described. The family (4,370 proteins, no Gene Ontology term, no solved structure) is uncharacterised across all organisms and essential in three Actinobacterial genera. A Foldseek search of the AlphaFold model against complete structural databases finds no significant homolog, indicating a novel fold. The operon eno-divIC-Rv1025-ppx2 is conserved across the Actinobacteria phylum, yet AlphaFold-Multimer finds no direct complex between Rv1025 and its neighbour DivIC. Instead, conservation across 8,700 homologous sequences reveals a near-invariant Cys113-His115-Glu59 cluster forming a pocket. Holo AlphaFold3 predictions with Zn, Fe and Mn confidently place a divalent metal on this triad at 2.25-2.47 A; mutating the triad relocates the metal, and an independent backbone-geometry predictor recovers the same site, confirming specificity. The triad is universal across the family: present in all 1,472 near-complete bacterial sequences of the Pfam alignment, with no non-conservative substitution among the 2,228 sequences examined, a defining feature of bacterial DUF501 rather than a mycobacterial peculiarity. We propose that DUF501 is a metal-binding protein and candidate metalloenzyme, the first functional hypothesis for this family, whose conserved, essential metal pocket is a promising drug target. As the predictions build on a conservation-defined site within a fully computational study, they are supportive rather than proof of metal occupancy and warrant experimental validation.

microbiology

Mycoplasmal endosymbionts of Trichomonas vaginalis are associated with reduced risk for Chlamydia trachomatis endometrial infection in asymptomatic, coinfected, women.

Trichomonas vaginalis is a protozoan parasite that causes trichomoniasis, the most common curable non-viral sexually transmitted infection, and Chlamydia trachomatis is a bacterial pathogen that can ascend to the upper genital tract and cause pelvic inflammatory disease, infertility, and ectopic pregnancy. T. vaginalis harbors bacterial endosymbionts, including Candidatus Malacoplasma girerdii, an obligate symbiont, and Metamycoplasma hominis, which can live freely or symbiotically. In a 16S rRNA sequencing study of the cervicovaginal microbiome of women at high risk for chlamydial infection, Ca. M. girerdii abundance was one of 13 features predicting lack of chlamydial spread to the endometrium, despite no direct association between T. vaginalis infection and reduced chlamydial ascension. Investigating the relationship between these microorganisms further, we found that T. vaginalis vaginal abundance correlated positively with chlamydial burden in women whose infection was confined to the cervix, while a nonsignificant inverse relationship was seen in women with endometrial spread. Among participants with high chlamydial burden, Ca. M. girerdii was detected exclusively in women without endometrial infection. Both endosymbionts trended toward more frequent detection, and higher abundance, in coinfected women without endometrial spread, while M. hominis abundance correlated strongly with T. vaginalis burden in this group. These findings suggest that mycoplasmal endosymbionts of T. vaginalis, rather than T. vaginalis itself, are microbial factors limiting chlamydial ascension, and point to a three-way interaction between parasite, endosymbiont, and bacterial pathogen that shapes upper genital tract C. trachomatis infection risk.

microbiology

Understanding the physiological alterations of Vibrio cholerae upon exposure to L-ascorbic acid

The scourge of cholera remains a major global public health threat. It affects up to 4 million people worldwide and causes tens of thousands of deaths each year. The disease is experiencing a concerning resurgence in many parts of Africa, the Middle East, and Asia. To effectively tackle cholera and circumvent rising antimicrobial resistance, targeted biological and preventive approaches, complementing traditional rehydration, are urgently needed. In this regard, our group has demonstrated the efficacy of L-ascorbic acid in controlling the growth and pathogenesis of Vibrio cholerae in vitro. The present work further provides a mechanistic elucidation of the L-ascorbic acid-mediated physiological changes in V. cholerae and also bolsters such a non-antibiotic approach to control cholera.

microbiology